OCUL - Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences | Benzinga
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular", the "Company")), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it will participate at two investor conferences in May:
Citizens JMP Life Sciences Conference
Fireside Chat Date: Monday, May 13, 2024
Fireside Chat Time: 1:00 PM ET
Location: New York, NY
BofA Securities 2024 Health Care Conference
Fireside Chat Date: Wednesday, May 15, 2024
Fireside Chat Time: 3:00 PM ...